← Merck & Co., Inc. MRK
Market Price
$135.84
Market Cap
$334.88B
P/E Ratio
18.66
Revenue (FY 2025)
↑1.3% YoY
$65.01B
3-Yr CAGR: 3.1%
Net Income
↑6.6% YoY
$18.25B
Net Margin: 28.1%
Free Cash Flow
↓-31.7% YoY
$12.36B
FCF Yield: 3.69%
EPS (Diluted)
↑8.0% YoY
$7.28
Basic: $7.30
Return on Equity
Efficiency
34.7%
ROA: 13.3%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (MRK)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $39,807.0M | — | $25,777.0M | $3,920.0M | — | $1.35 | — | $10,376.0M | $8,762.0M | — |
| FY 2017 | $40,122.0M | +0.8% | $27,210.0M | $2,394.0M | -38.9% | $0.83 | -38.3% | $6,447.0M | $4,559.0M | -48.0% |
| FY 2018 | $42,294.0M | +5.4% | $28,785.0M | $6,220.0M | +159.8% | $2.21 | +166.7% | $10,922.0M | $8,307.0M | +82.2% |
| FY 2019 | $46,840.0M | +10.7% | $32,728.0M | $9,843.0M | +58.2% | $3.64 | +64.2% | $13,440.0M | $9,967.0M | +20.0% |
| FY 2020 | $47,994.0M | +2.5% | $32,509.0M | $7,067.0M | -28.2% | $2.65 | -27.0% | $10,253.0M | $5,569.0M | -44.1% |
| FY 2021 | $48,704.0M | +1.5% | $35,078.0M | $13,049.0M | +84.6% | $5.14 | +93.8% | $987.0M | $-3,461.0M | -162.1% |
| FY 2022 | $59,283.0M | +21.7% | $41,872.0M | $14,519.0M | +11.3% | $5.71 | +11.1% | — | $-4,388.0M | -26.8% |
| FY 2023 | $60,115.0M | +1.4% | $43,989.0M | $365.0M | -97.5% | $0.14 | -97.5% | — | $-3,863.0M | +12.0% |
| FY 2024 | $64,168.0M | +6.7% | $48,975.0M | $17,117.0M | +4,589.6% | $6.74 | +4,714.3% | $21,468.0M | $18,096.0M | +568.4% |
| FY 2025 | $65,011.0M | +1.3% | $48,629.0M | $18,254.0M | +6.6% | $7.28 | +8.0% | $16,472.0M | $12,360.0M | -31.7% |
Valuation
Market Price
$135.84
Market Cap
$334.88B
Enterprise Value
$369.37B
P/E Ratio
18.66
P/B Ratio
6.38
FCF Yield
3.69%
Dividend Yield
2.41%
Shares Outstanding
Profitability & Margins
Gross Margin
74.80%
Operating Margin
0.23%
Net Margin
28.08%
Return on Equity (ROE)
34.70%
Return on Assets (ROA)
13.34%
Asset Turnover
0.47x
Revenue 3-Yr CAGR
3.12%
Financial Health & Liquidity
Current Ratio
1.54
Cash Ratio
0.51
Debt / Equity
0.932
Debt / Assets
0.358
Cash & Equivalents
$14.56B
Total Debt
$49.05B
Book Value / Share
$21.30
Cash Flow Efficiency
Operating Cash Flow
$16.47B
Capital Expenditures (CapEx)
$4.11B
Free Cash Flow
$12.36B
OCF / Revenue
25.34%
FCF / Revenue
19.01%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$7.28
EPS (Basic)
$7.30
Dividends / Share
$3.28
Book Value / Share
$21.30
EPS YoY Growth
8.01%
Balance Sheet (FY 2025)
Total Assets
$136.87B
Total Liabilities
$136.87B
Stockholders' Equity
$52.61B
Current Assets
$43.52B
Current Liabilities
$28.33B